A Maresin 1/Rorα/12-Lipoxygenase Autoregulatory Circuit Prevents Inflammation and Progression of Nonalcoholic Steatohepatitis

Macrophage Polarization

Murray, P. J. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034339 · Cited by 2,981 · see citing works

GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects

Oh, D. Y., Talukdar, S., Bae, E. J., Imamura, T., Morinaga, H., Fan, W., Li, P., Lu, W. J., Watkins, S. M., & Olefsky, J. M. (2010) · Cell · doi:10.1016/j.cell.2010.07.041 · Cited by 2,428 · see citing works

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): A multicentre, randomised, placebo-controlled trial

Neuschwander-Tetri, B. A., Loomba, R., Sanyal, A. J., Lavine, J. E., Van Natta, M. L., Abdelmalek, M. F., Chalasani, N., Dasarathy, S., Diehl, A. M., Hameed, B., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61933-4 · Cited by 2,237 · see citing works

Liver Macrophages in Tissue Homeostasis and Disease

Krenkel, O., & Tacke, F. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.11 · Cited by 1,424 · see citing works

A lipidomic analysis of nonalcoholic fatty liver disease

Puri, P., Baillie, R. A., Wiest, M. M., Mirshahi, F., Choudhury, J., Cheung, O., Sargeant, C., Contos, M. J., & Sanyal, A. J. (2007) · Hepatology · doi:10.1002/hep.21763 · Cited by 1,338 · see citing works

Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages

Huang, S. C., Everts, B., Ivanova, Y., O’Sullivan, D., Nascimento, M., Smith, A. M., Beatty, W. L., Love-Gregory, L. D., Lam, W. Y., O’Neill, C. M., et al. (2014) · Nature Immunology · doi:10.1038/ni.2956 · Cited by 1,215 · see citing works

Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening

Ratziu, V., Harrison, S. A., Francque, S., Bedossa, P., Lehert, P., Serfaty, L., Romero-Gomez, M., Boursier, J., Abdelmalek, M., Caldwell, S., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.01.038 · Cited by 1,035 · see citing works

Maresins: Novel macrophage mediators with potent antiinflammatory and proresolving actions

Serhan, C. N., Yang, R., Martinod, K., Kasuga, K., Pillai, P. S., Porter, T. F., Oh, S. F., & Spite, M. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081880 · Cited by 908 · see citing works

Proresolving Lipid Mediators and Mechanisms in the Resolution of Acute Inflammation

Buckley, C. D., Gilroy, D. W., & Serhan, C. N. (2014) · Immunity · doi:10.1016/j.immuni.2014.02.009 · Cited by 811 · see citing works

Retinoid-Related Orphan Receptors (RORs): Critical Roles in Development, Immunity, Circadian Rhythm, and Cellular Metabolism

Jetten, A. M. (2009) · Nuclear Receptor Signaling · doi:10.1621/nrs.07003 · Cited by 675 · see citing works

Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human

Ichimura, A., Hirasawa, A., Poulain‐Godefroy, O., Bonnefond, A., Hara, T., Yengo, L., Kimura, I., Leloire, A., Liu, N., Iida, K., et al. (2012) · Nature · doi:10.1038/nature10798 · Cited by 663 · see citing works

The plasma lipidomic signature of nonalcoholic steatohepatitis

Puri, P., Wiest, M. M., Cheung, O., Mirshahi, F., Sargeant, C., Min, H., Contos, M. J., Sterling, R. K., Fuchs, M., Zhou, H., et al. (2009) · Hepatology · doi:10.1002/hep.23229 · Cited by 655 · see citing works

Omega-3 supplementation and non-alcoholic fatty liver disease: A systematic review and meta-analysis

Parker, H. M., Johnson, N. A., Burdon, C. A., Cohn, J. S., O’Connor, H. T., & George, J. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.08.018 · Cited by 569 · see citing works

M2 Kupffer cells promote M1 Kupffer cell apoptosis: A protective mechanism against alcoholic and nonalcoholic fatty liver disease

Wan, J., Benkdane, M., Teixeira-Clerc, F., Bonnafous, S., Louvet, A., Lafdil, F., Pecker, F., Tran, A., Gual, P., Mallat, A., et al. (2014) · Hepatology · doi:10.1002/hep.26607 · Cited by 558 · see citing works

Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators

Dalli, J., & Serhan, C. N. (2012) · Blood · doi:10.1182/blood-2012-04-423525 · Cited by 556 · see citing works

Fat-1 mice convert n-6 to n-3 fatty acids

Kang, J. X., Wang, J., Wu, L., & Kang, Z. B. (2004) · Nature · doi:10.1038/427504a · Cited by 545 · see citing works

Specialized pro-resolving lipid mediators in the inflammatory response: An update

Bannenberg, G., & Serhan, C. N. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.08.002 · Cited by 464 · see citing works

Resolvins, Specialized Proresolving Lipid Mediators, and Their Potential Roles in Metabolic Diseases

Spite, M., Clària, J., & Serhan, C. N. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2013.10.006 · Cited by 464 · see citing works

Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue

Colas, R. A., Shinohara, M., Dalli, J., Chiang, N., & Serhan, C. N. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00024.2014 · Cited by 424 · see citing works

Resolvin D1 and Its Precursor Docosahexaenoic Acid Promote Resolution of Adipose Tissue Inflammation by Eliciting Macrophage Polarization toward an M2-Like Phenotype

Titos, E., Rius, B., González-Périz, A., López-Vicario, C., Morán-Salvador, E., Martínez-Clemente, M., Arroyo, V., & Clària, J. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100225 · Cited by 412 · see citing works

NASH is an Infl ammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications

Farrell, G. C., Rooyen, D. M. V., Gan, L. T., & Chitturi, S. (2012) · Gut and Liver · doi:10.5009/gnl.2012.6.2.149 · Cited by 396 · see citing works

Identification of resolvin D2 receptor mediating resolution of infections and organ protection

Chiang, N., Dalli, J., Colas, R. A., & Serhan, C. N. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20150225 · Cited by 388 · see citing works

SREBP1 Contributes to Resolution of Pro-inflammatory TLR4 Signaling by Reprogramming Fatty Acid Metabolism

Oishi, Y., Spann, N. J., Link, V. M., Muse, E. D., Strid, T., Edillor, C., Kolar, M. J., Matsuzaka, T., Hayakawa, S., Tao, J., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.11.009 · Cited by 342 · see citing works

Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors

Chiang, N., & Serhan, C. N. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.03.005 · Cited by 330 · see citing works

Functional and pathological roles of the 12- and 15-lipoxygenases

Dobrian, A. D., Lieb, D. C., Cole, B. K., Taylor, D., Chakrabarti, S. K., & Nadler, J. L. (2010) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.10.005 · Cited by 324 · see citing works

Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: Results from the WELCOME* study

Scorletti, E., Bhatia, L. S., McCormick, K. G., Clough, G. F., Nash, K. L., Hodson, L., Moyses, H. E., Calder, P. C., Byrne, C. D., Sheron, N., et al. (2014) · Hepatology · doi:10.1002/hep.27289 · Cited by 310 · see citing works

The novel 13 <i>S</i> ,14 <i>S</i> ‐epoxy‐maresin is converted by human macrophages to maresin 1 (MaR1), inhibits leukotriene A ₄ hydrolase (LTA ₄ H), and shifts macrophage phenotype

Dalli, J., Zhu, M., Vlasenko, N. A., Deng, B., Haeggström, J. Z., Petasis, N. A., & Serhan, C. N. (2013) · The FASEB Journal · doi:10.1096/fj.13-227728 · Cited by 283 · see citing works

Selective inhibition of platelet lipoxygenase by baicalein

Sekiya, K., & Okuda, H. (1982) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(82)91081-6 · Cited by 248 · see citing works

The lipid sensor GPR120 promotes brown fat activation and FGF21 release from adipocytes

Quesada‐López, T., Cereijo, R., Turatsinze, J., Planavila, A., Cairó, M., Gavaldà‐Navarro, A., Peyrou, M., Moure, R., Iglesias, R., Giralt, M., et al. (2016) · Nature Communications · doi:10.1038/ncomms13479 · Cited by 231 · see citing works

Effects of n-3 fish oil on metabolic and histological parameters in NASH: a double-blind, randomized, placebo-controlled trial

Argo, C. K., Patrie, J. T., Lackner, C., Henry, T. D., de Lange, E. E., Weltman, A. L., Shah, N. L., Al-Osaimi, A. M., Pramoonjago, P., Jayakumar, S., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.08.036 · Cited by 224 · see citing works

Crystal Structure of the Human RORα Ligand Binding Domain in Complex with Cholesterol Sulfate at 2.2 Å

Kallen, J. A., Schlaeppi, J.-M., Bitsch, F., Delhon, I., & Fournier, B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400302200 · Cited by 219 · see citing works

Identification and Actions of the Maresin 1 Metabolome in Infectious Inflammation

Colas, R. A., Dalli, J., Chiang, N., Vlasakov, I., Sanger, J. M., Riley, I. R., & Serhan, C. N. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600837 · Cited by 180 · see citing works

NCoR Repression of LXRs Restricts Macrophage Biosynthesis of Insulin-Sensitizing Omega 3 Fatty Acids

Li, P., Spann, N. J., Kaikkonen, M. U., Lu, M. M., Oh, D. Y., Fox, J. N., Bandyopadhyay, G. K., Talukdar, S., Xu, J., Lagakos, W., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.054 · Cited by 177 · see citing works

Maresin 1 Biosynthesis and Proresolving Anti-infective Functions with Human-Localized Aggressive Periodontitis Leukocytes

Wang, C., Colas, R. A., Dalli, J., Arnardottir, H. H., Nguyen, D., Hastürk, H., Chiang, N., Dyke, T. E. V., & Serhan, C. N. (2015) · Infection and Immunity · doi:10.1128/iai.01131-15 · Cited by 172 · see citing works

Maresin 1 mitigates liver steatosis in ob/ob and diet-induced obese mice

Laiglesia, L. M., Lorente‐Cebrián, S., Martínez‐Fernández, L., Sáinź, N., Prieto-Hontoria, P. L., Burrell, M. A., Rodríguez‐Ortigosa, C. M., Martínez, J. A., & Moreno-Aliaga, M. J. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.226 · Cited by 167 · see citing works

Identification of SR1078, a Synthetic Agonist for the Orphan Nuclear Receptors RORα and RORγ

Wang, Y., Kumar, N., Nuhant, P., Cameron, M. D., Istrate, M. A., Roush, W. R., Griffin, P. R., & Burris, T. P. (2010) · ACS Chemical Biology · doi:10.1021/cb100223d · Cited by 164 · see citing works

Double-blind Randomized Placebo-controlled Clinical Trial of Omega 3 Fatty Acids for the Treatment of Diabetic Patients With Nonalcoholic Steatohepatitis

Dasarathy, S., Dasarathy, J., Khiyami, A., Yerian, L. M., Hawkins, C., Sargent, R., & McCullough, A. J. (2014) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000099 · Cited by 161 · see citing works

RORα Induces KLF4-Mediated M2 Polarization in the Liver Macrophages that Protect against Nonalcoholic Steatohepatitis

Han, Y., Kim, H., Na, H., Nam, M.-W., Kim, J.-Y., Kim, J.-S., Koo, S., & Lee, M.-O. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.06.017 · Cited by 150 · see citing works

X‐ray structure of the orphan nuclear receptor RORβ ligand‐binding domain in the active conformation

Stehlin, C., Wurtz, J., Steinmetz, A. C. U., Greiner, E. F., Schüle, R., Moras, D., & Renaud, J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.21.5822 · Cited by 125 · see citing works

Metabolomics‐Lipidomics of Eicosanoids and Docosanoids Generated by Phagocytes

Yang, R., Chiang, N., Oh, S. F., & Serhan, C. N. (2011) · Current Protocols in Immunology · doi:10.1002/0471142735.im1426s95 · Cited by 104 · see citing works

Maresin 1 improves insulin sensitivity and attenuates adipose tissue inflammation in ob/ob and diet‐induced obese mice

Martínez‐Fernández, L., González‐Muniesa, P., Laiglesia, L. M., Sáinź, N., Prieto-Hontoria, P. L., Escoté, X., Odriozola, L., Corrales, F. J., Arbonés-Mainar, J. M., Martínez, J. A., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201600859r · Cited by 104 · see citing works

Mammalian ALOX15 orthologs exhibit pronounced dual positional specificity with docosahexaenoic acid

Kutzner, L., Goloshchapova, K., Heydeck, D., Stehling, S., Kühn, H., & Schebb, N. H. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.04.001 · Cited by 91 · see citing works

Opportunities and Challenges for Fatty Acid Mimetics in Drug Discovery

Proschak, E., Heitel, P., Kalinowsky, L., & Merk, D. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01287 · Cited by 89 · see citing works

Transcriptional Activation of HIF-1 by RORα and its Role in Hypoxia Signaling

Kim, E., Yoo, Y., Yang, W., Lim, Y.-S., Na, T., Lee, I., & Lee, M. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.171546 · Cited by 85 · see citing works

RORα Decreases Oxidative Stress Through the Induction of SOD2 and GPx1 Expression and Thereby Protects Against Nonalcoholic Steatohepatitis in Mice

Han, Y., Kim, H., Kim, E., Kim, K.-S., Hong, S., Park, H., & Lee, M. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5655 · Cited by 84 · see citing works

Impairment of systemic DHA synthesis affects macrophage plasticity and polarization: implications for DHA supplementation during inflammation

Talamonti, E., Pauter, A. M., Asadi, A., Fischer, A. W., Chiurchiù, V., & Jacobsson, A. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2498-9 · Cited by 81 · see citing works

Endogenously synthesized n-3 polyunsaturated fatty acids in fat-1 mice ameliorate high-fat diet-induced non-alcoholic fatty liver disease

Kim, E., Bae, J.-S., Hahm, K. B., & Cha, J.-Y. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.08.029 · Cited by 77 · see citing works

Disruption of the 12/15-Lipoxygenase Gene (Alox15) Protects Hyperlipidemic Mice from Nonalcoholic Fatty Liver Disease

Martínez‐Clemente, M., Ferré, N., Titos, E., Horrillo, R., González‐Périz, A., Morán‐Salvador, E., López‐Vicario, C., Miquel, R., Arroyo, V., Funk, C. D., et al. (2010) · Hepatology · doi:10.1002/hep.23928 · Cited by 71 · see citing works

Discovery of Potent and Selective Inhibitors of Human Platelet-Type 12- Lipoxygenase

Kenyon, V. A., Rai, G., Jadhav, A., Schultz, L., Armstrong, M. M., Jameson, J. B., Perry, S., Joshi, N., Bougie, J. M., Leister, W., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2005089 · Cited by 69 · see citing works

Retinoic acid receptor–related orphan receptor α–induced activation of adenosine monophosphate–activated protein kinase results in attenuation of hepatic steatosis

Kim, E., Yoon, Y.-S., Hong, S., Son, H.-Y., Na, T., Lee, M., Kang, H.-J., Park, J., Cho, W., Kim, S.-G., et al. (2011) · Hepatology · doi:10.1002/hep.25529 · Cited by 65 · see citing works

Docosahexaenoic acid enrichment in NAFLD is associated with improvements in hepatic metabolism and hepatic insulin sensitivity: a pilot study

Hodson, L., Bhatia, L. S., Scorletti, E., Smith, D. E., Jackson, N. C., Shojaee‐Moradie, F., Umpleby, A. M., Calder, P. C., & Byrne, C. D. (2017) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2017.9 · Cited by 63 · see citing works

Effects of obesity/fatty acids on the expression of GPR120

Rodríguez‐Pacheco, F., García‐Serrano, S., García‐Escobar, E., Gutiérrez‐Repiso, C., García-Arnés, J. A., Valdés, S., Gonzalo, M., Soriguer, F., Moreno‐Ruiz, F. J., Rodríguez‐Cañete, A., et al. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300666 · Cited by 45 · see citing works

Liver-specific deletion of RORα aggravates diet-induced nonalcoholic steatohepatitis by inducing mitochondrial dysfunction

Kim, H., Han, Y., Na, H., Kim, J., Kim, T.-W., Kim, H., Shin, C., Lee, S. E., & Lee, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-16077-y · Cited by 45 · see citing works

Regulation of the Human Hydroxysteroid Sulfotransferase (SULT2A1) by RORα and RORγ and Its Potential Relevance to Human Liver Diseases

Ou, Z., Shi, X., Gilroy, R. K., Kirisci, L., Romkes, M., Lynch, C., Wang, H., Xu, M., Jiang, M., Ren, S., et al. (2012) · Molecular Endocrinology · doi:10.1210/me.2012-1145 · Cited by 38 · see citing works

Expression of retinoic acid-related orphan receptor alpha and its responsive genes in human endometrium regulated by cholesterol sulfate

Zenri, F., Hiroi, H., Momoeda, M., Tsutsumi, R., Hosokawa, Y., Koizumi, M., Nakae, H., Osuga, Y., Yano, T., & Taketani, Y. (2011) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.10.001 · Cited by 15 · see citing works

Erratum: Docosahexaenoic acid enrichment in NAFLD is associated with improvements in hepatic metabolism and hepatic insulin sensitivity: a pilot study

Hodson, L., Bhatia, L. S., Scorletti, E., Smith, D. E., Jackson, N. C., Shojaee‐Moradie, F., Umpleby, M., Calder, P. C., & Byrne, C. D. (2017) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2017.145 · Cited by 9 · see citing works

Mechanisms and disease consequences of nonalcoholic fatty liver disease

Loomba, R., Friedman, S. L., & Shulman, G. I. (2021) · Cell · doi:10.1016/j.cell.2021.04.015 · Cited by 2,002 · see citing works

Polyunsaturated fatty acids and fatty acid-derived lipid mediators: Recent advances in the understanding of their biosynthesis, structures, and functions

Dyall, S. C., Balas, L., Bazan, N. G., Brenna, J. T., Chiang, N., Souza, F. D. C., Dalli, J., Durand, T., Galano, J., Lein, P. J., et al. (2022) · Progress in Lipid Research · doi:10.1016/j.plipres.2022.101165 · Cited by 681 · see citing works

Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease – novel insights into cellular communication circuits

Peiseler, M., Schwabe, R., Hampe, J., Kubes, P., Heikenwälder, M., & Tacke, F. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.06.012 · Cited by 564 · see citing works

Specialized pro-resolving mediator network: an update on production and actions

Chiang, N., & Serhan, C. N. (2020) · Essays in Biochemistry · doi:10.1042/ebc20200018 · Cited by 441 · see citing works

Hepatic fibrosis 2022: Unmet needs and a blueprint for the future

Friedman, S. L., & Pinzani, M. (2022) · Hepatology · doi:10.1002/hep.32285 · Cited by 430 · see citing works

Maresin 1 activates LGR6 receptor promoting phagocyte immunoresolvent functions

Chiang, N., Libreros, S., Norris, P. C., de la Rosa, X., & Serhan, C. N. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129448 · Cited by 251 · see citing works

A multiancestry genome-wide association study of unexplained chronic ALT elevation as a proxy for nonalcoholic fatty liver disease with histological and radiological validation

Vujkovic, M., Ramdas, S., Lorenz, K. M., Guo, X., Darlay, R., Cordell, H. J., He, J., Gindin, Y., Chung, C., Myers, R. P., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01078-z · Cited by 205 · see citing works

Hepatic macrophages: Key players in the development and progression of liver fibrosis

Cheng, D., Chai, J., Wang, H., Fu, L., Peng, S., & Ni, X. (2021) · Liver International · doi:10.1111/liv.14940 · Cited by 188 · see citing works

Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH)

Wang, S., & Friedman, S. L. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adi0759 · Cited by 158 · see citing works

Innate Immunity in Diabetic Wound Healing: Focus on the Mastermind Hidden in Chronic Inflammatory

Geng, K., Ma, X., Jiang, Z., Huang, W. G., Gao, C., Pu, Y., Luo, L., Xu, Y., & Xu, Y. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.653940 · Cited by 121 · see citing works

Maresin 1 promotes nerve regeneration and alleviates neuropathic pain after nerve injury

Wei, J., Su, W., Zhao, Y., Wei, Z., Hua, Y., Xue, P., Zhu, X., Chen, Y., & Chen, G. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02405-1 · Cited by 107 · see citing works

Brown adipose tissue-derived MaR2 contributes to cold-induced resolution of inflammation

Sugimoto, S., Mena, H. A., Sansbury, B. E., Kobayashi, S., Tsuji, T., Wang, C., Yin, X., Huang, T. L., Kusuyama, J., Kodani, S. D., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00590-0 · Cited by 108 · see citing works

The Role and Mechanism of Oxidative Stress and Nuclear Receptors in the Development of NAFLD

Hong, T., Chen, Y., Li, X., & Lü, Y. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6889533 · Cited by 104 · see citing works

Hepatic macrophage targeted siRNA lipid nanoparticles treat non-alcoholic steatohepatitis

Zhou, J.-E., Sun, L., Liu, L., Jia, Y., Han, Y., Shao, J., Wang, J., Wang, Y., Yu, L., & Yan, Z. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.01.038 · Cited by 104 · see citing works

Specialized Pro-Resolving Mediators as Resolution Pharmacology for the Control of Pain and Itch

Ji, R. (2022) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-051921-084047 · Cited by 107 · see citing works

Immuno‐Resolving Ability of Resolvins, Protectins, and Maresins Derived from Omega‐3 Fatty Acids in Metabolic Syndrome

Kwon, Y. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900824 · Cited by 88 · see citing works

ROR: Nuclear Receptor for Melatonin or Not?

Ma, H., Kang, J., Fan, W., He, H., & Huang, F. P. (2021) · Molecules · doi:10.3390/molecules26092693 · Cited by 81 · see citing works

Hepatic Stellate Cell-Immune Interactions in NASH

Carter, J. K., & Friedman, S. L. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.867940 · Cited by 79 · see citing works

Maresin-1 Prevents Liver Fibrosis by Targeting Nrf2 and NF-κB, Reducing Oxidative Stress and Inflammation

Rodrí­guez, M. J., Sabaj, M., Tolosa, G., Vielma, F. H., Zúñiga, M. J., González, D. R., & Zúñiga‐Hernández, J. (2021) · Cells · doi:10.3390/cells10123406 · Cited by 78 · see citing works

Specialized Pro-resolving Lipid Mediators and Glial Cells: Emerging Candidates for Brain Homeostasis and Repair

Tiberi, M., & Chiurchiù, V. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.673549 · Cited by 75 · see citing works

Maresin-1 and Inflammatory Disease

Saito‐Sasaki, N., Sawada, Y., & Nakamura, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031367 · Cited by 78 · see citing works

Damage-mediated macrophage polarization in sterile inflammation

Koncz, G., Jenei, V., Tóth, M., Váradi, E., Kardos, B., Bácsi, A., & Mázló, A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1169560 · Cited by 71 · see citing works

Lipidomics in pathogenesis, progression and treatment of nonalcoholic steatohepatitis (NASH): Recent advances

Musso, G., Saba, F., Cassader, M., & Gambino, R. (2023) · Progress in Lipid Research · doi:10.1016/j.plipres.2023.101238 · Cited by 67 · see citing works

Triglyceride lowering by omega-3 fatty acids: a mechanism mediated by N-acyl taurines

Bornfeldt, K. E. (2021) · Journal of Clinical Investigation · doi:10.1172/jci147558 · Cited by 58 · see citing works

Reprogramming of Hepatic Metabolism and Microenvironment in Nonalcoholic Steatohepatitis

Rui, L., & Lin, J. D. (2022) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-062220-105200 · Cited by 56 · see citing works

Treating inflammation to combat non-alcoholic fatty liver disease

Wiering, L., & Tacke, F. (2022) · Journal of Endocrinology · doi:10.1530/joe-22-0194 · Cited by 58 · see citing works

Beneficial Effects of Omega-3 Fatty Acids on Obesity and Related Metabolic and Chronic Inflammatory Diseases

Jerab, D., Blangero, F., da Costa, P. C. T., Alves, J. L. D. B., Kéfi, R., Jamoussi, H., Morio, B., & Eljaafari, A. (2025) · Nutrients · doi:10.3390/nu17071253 · Cited by 55 · see citing works

Inhibition of nuclear receptor RORα attenuates cartilage damage in osteoarthritis by modulating IL-6/STAT3 pathway

Liang, T., Chen, T., Qiu, J., Gao, W., Qiu, X., Zhu, Y., Wang, X., Chen, Y., Zhou, H., Deng, Z., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04170-0 · Cited by 54 · see citing works

Maresin-1 suppresses IL-1β-induced MMP-13 secretion by activating the PI3K/AKT pathway and inhibiting the NF-κB pathway in synovioblasts of an osteoarthritis rat model with treadmill exercise

Lu, J., Feng, X., Zhang, H., Wei, Y., Yang, Y., Tian, Y., & Bai, L. (2020) · Connective Tissue Research · doi:10.1080/03008207.2020.1780218 · Cited by 53 · see citing works

Omega-3 Lipid Mediators: Modulation of the M1/M2 Macrophage Phenotype and Its Protective Role in Chronic Liver Diseases

Videla, L. A., Valenzuela, R., del Campo, A., & Zúñiga‐Hernández, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115528 · Cited by 51 · see citing works

Potential Clinical Applications of Pro-Resolving Lipids Mediators from Docosahexaenoic Acid

Beyer, M. P., Videla, L. A., Farías, C., & Valenzuela, R. (2023) · Nutrients · doi:10.3390/nu15153317 · Cited by 51 · see citing works

Multiple omics study identifies an interspecies conserved driver for nonalcoholic steatohepatitis

Zhang, X., She, Z., Wang, J., Sun, D., Shen, L., Xiang, H., Cheng, X., Ji, Y., Huang, Y., Li, P., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abg8117 · Cited by 49 · see citing works

Resolvin D1 protects against sepsis‐induced cardiac injury in mice

Wang, M., Liu, M., Zhang, J., Liu, J., Ye, J., Xu, Y. Q., Wang, Z., Ye, D., Zhao, M., & Wan, J. (2020) · BioFactors · doi:10.1002/biof.1668 · Cited by 48 · see citing works

Maresin-1 resolution with RORα and LGR6

Im, D. (2020) · Progress in Lipid Research · doi:10.1016/j.plipres.2020.101034 · Cited by 46 · see citing works

Effect of ω-3 Polyunsaturated Fatty Acids-Derived Bioactive Lipids on Metabolic Disorders

Duan, J., Song, Y., Zhang, X., & Wang, C. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.646491 · Cited by 47 · see citing works

Bioactive signalling lipids as drivers of chronic liver diseases

Kaffe, E., Tisi, A., Magkrioti, C., Aidinis, V., Mehal, W. Z., Flavell, R. A., & Maccarrone, M. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.08.029 · Cited by 43 · see citing works

Specialized Proresolving Mediators for Therapeutic Interventions Targeting Metabolic and Inflammatory Disorders

Han, Y., KyeongJin, L., Saha, A., Han, J., Choi, H., Noh, M., Lee, Y., & Lee, M. (2021) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2021.094 · Cited by 40 · see citing works

A structurally engineered fatty acid, icosabutate, suppresses liver inflammation and fibrosis in NASH

Fraser, D. A., Wang, X., Lund, J., Nikolić, N., Iruarrizaga-Lejarreta, M., Skjaeret, T., Alonso, C., Kastelein, J. J. P., Rustan, A. C., Kim, Y. O., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2021.12.004 · Cited by 41 · see citing works

Maresin: Macrophage Mediator for Resolving Inflammation and Bridging Tissue Regeneration—A System-Based Preclinical Systematic Review

Liu, W., Yang, Y.-H., Wang, Y.-C., Chang, W., & Wang, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311012 · Cited by 39 · see citing works

Alzheimer’s Disease and Specialized Pro-Resolving Lipid Mediators: Do MaR1, RvD1, and NPD1 Show Promise for Prevention and Treatment?

Miyazawa, K., Fukunaga, H., Tatewaki, Y., Takano, Y., Yamamoto, S., Mutoh, T., & Taki, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165783 · Cited by 38 · see citing works

Bioactive Lipid Mediators in the Initiation and Resolution of Inflammation after Spinal Cord Injury

David, S., & López‐Vales, R. (2021) · Neuroscience · doi:10.1016/j.neuroscience.2021.04.026 · Cited by 39 · see citing works

Role of Specialized Pro-Resolving Mediators in Neuropathic Pain

Leuti, A., Fava, M., Pellegrini, N., & Maccarrone, M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.717993 · Cited by 37 · see citing works

The dual role of lipids in chronic kidney disease: Pathogenic culprits and therapeutic allies

Giardini, E., Moore, D., Sadlier, D. M., Godson, C., & Brennan, E. P. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.118615 · Cited by 36 · see citing works

Specialized pro-resolving lipid mediators: a key player in resolving inflammation in autoimmune diseases

Zhang, Q., Wang, Y., Zhu, J., Zou, M., Zhang, Y., Wu, H., & Jin, T. (2025) · 中国科学通报：英文版 · doi:10.1016/j.scib.2024.07.049 · Cited by 35 · see citing works

Targeting peripheral immune organs with self-assembling prodrug nanoparticles ameliorates allogeneic heart transplant rejection

Zhou, K., Chen, X., Zhang, L., Yang, Z., Zhu, H. H., Guo, D., Su, R., Chen, H., Li, H., Song, P., et al. (2021) · American Journal of Transplantation · doi:10.1111/ajt.16748 · Cited by 35 · see citing works

An abundant biliary metabolite derived from dietary omega-3 polyunsaturated fatty acids regulates triglycerides

Grevengoed, T. J., Trammell, S. A. J., Svenningsen, J. S., Makarov, M. V., Nielsen, T. S., Jacobsen, J. C., Treebak, J. T., Calder, P. C., Migaud, M. E., Cravatt, B. F., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci143861 · Cited by 34 · see citing works

Maresin 1 protects the liver against ischemia/reperfusion injury via the ALXR/Akt signaling pathway

Tang, D., Fu, G., Li, W., Sun, P., Loughran, P., Deng, M., Scott, M. J., & Billiar, T. R. (2021) · Molecular Medicine · doi:10.1186/s10020-021-00280-9 · Cited by 33 · see citing works

MCTR1 inhibits ferroptosis by promoting NRF2 expression to attenuate hepatic ischemia-reperfusion injury

Ye, J., Peng, J., Liu, K., Zhang, T., & Huang, W. (2022) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00354.2021 · Cited by 33 · see citing works

Eicosanoids and other oxylipins in liver injury, inflammation and liver cancer development

Alba, M. M., Ebright, B., Hua, B., Slarve, I., Zhou, Y., Jia, Y., Louie, S. G., & Stiles, B. L. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1098467 · Cited by 32 · see citing works

Decreased Plasma Maresin 1 Concentration Is Associated with Diabetic Foot Ulcer

Tian, M., Huang, B., He, N., Sun, L., Du, G., Gong, X., Xu, Y., Zheng, Y., Zheng, H., & Qu, H. (2020) · Mediators of Inflammation · doi:10.1155/2020/4539035 · Cited by 31 · see citing works

Hepatocyte Smoothened Activity Controls Susceptibility to Insulin Resistance and Nonalcoholic Fatty Liver Disease

Chen, T., Dalton, G. D., Oh, S., Maeso‐Díaz, R., Du, K., Meyers, R. A., Guy, C. D., Abdelmalek, M. F., Henao, R., Guarnieri, P., et al. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.12.008 · Cited by 31 · see citing works

Maresin 1 activates brown adipose tissue and promotes browning of white adipose tissue in mice

Laiglesia, L. M., Escoté, X., Sáinź, N., Félix‐Soriano, E., Santamaría, E., Collantes, M., Fernández‐Galilea, M., Colón-Mesa, I., Martínez‐Fernández, L., Quesada‐López, T., et al. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101749 · Cited by 31 · see citing works

Immune cells and their derived microRNA-enriched extracellular vesicles in nonalcoholic fatty liver diseases: Novel therapeutic targets.

Yang, L., Hao, Y., Boeckmans, J., Rodrigues, R., & He, Y. (2023) · Pharmacology and Therapeutics · doi:10.1016/j.pharmthera.2023.108353 · Cited by 27 · see citing works

The diverse roles of macrophages in metabolic inflammation and its resolution

Guha-Ray, A., Odum, O., Wiseman, D., & Weinstock, A. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1147434 · Cited by 29 · see citing works

Mechanisms of liver fibrosis in metabolic syndrome

Mehal, W. (2023) · eGastroenterology · doi:10.1136/egastro-2023-100015 · Cited by 28 · see citing works

Arachidonic acid metabolism in metabolic dysfunction–associated steatotic liver disease and liver fibrosis

Ma, Y., Jiang, J., Zhao, C., Wei, B., & Gao, J. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000802 · Cited by 28 · see citing works

Nobiletin Alleviates Non-alcoholic Steatohepatitis in MCD-Induced Mice by Regulating Macrophage Polarization

Wang, S.-W., Lan, T., Sheng, H., Zheng, F., Lei, M.-K., Wang, L.-X., Chen, H.-F., Xu, C.-Y., & Zhang, F. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.687744 · Cited by 28 · see citing works

Role of Omega-3 Fatty Acids as Non-Photic Zeitgebers and Circadian Clock Synchronizers

Checa-Ros, A., & D’Marco, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012162 · Cited by 28 · see citing works

Maresin 1 Regulates Hepatic FGF21 in Diet‐Induced Obese Mice and in Cultured Hepatocytes

Martínez‐Fernández, L., González‐Muniesa, P., Sáinź, N., Laiglesia, L. M., Escoté, X., Martínez, J. A., & Moreno-Aliaga, M. J. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900358 · Cited by 26 · see citing works

Maresin-1 induces cardiomyocyte hypertrophy through IGF-1 paracrine pathway

Wahyuni, T., Kobayashi, A., Tanaka, S., Miyake, Y., Yamamoto, A., Bahtiar, A., Mori, S., Kametani, Y., Tomimatsu, M., Matsumoto, K., et al. (2021) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00568.2020 · Cited by 26 · see citing works

Maresin1 Decreased Microglial Chemotaxis and Ameliorated Inflammation Induced by Amyloid-β ₄₂ in Neuron-Microglia Co-Culture Models

Yin, P., Wang, S., Wei, Y., Wang, X., Zhang, J., Yin, X., Feng, J., & Zhu, M. (2020) · Journal of Alzheimer’s Disease · doi:10.3233/jad-190682 · Cited by 24 · see citing works

Effects of Maresin 1 (MaR1) on Colonic Inflammation and Gut Dysbiosis in Diet-Induced Obese Mice

León, I. C., Quesada‐Vázquez, S., Sáinź, N., Guruceaga, E., Escoté, X., & Moreno-Aliaga, M. J. (2020) · Microorganisms · doi:10.3390/microorganisms8081156 · Cited by 24 · see citing works

Maternal diabetes-mediated RORA suppression in mice contributes to autism-like offspring through inhibition of aromatase

Yu, H. Y., Niu, Y., Jia, G., Liang, Y., Chen, B., Sun, R., Wang, M., Huang, S., Zeng, J., Lu, J., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03005-8 · Cited by 24 · see citing works

Omega-3 derivatives, specialized pro-resolving mediators: Promising therapeutic tools for the treatment of pain in chronic liver disease

Mariqueo, T. A., & Zúñiga‐Hernández, J. (2020) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2020.102095 · Cited by 24 · see citing works

Resolution of chronic inflammation and cancer

Tezcan, G., Yakar, N., Hastürk, H., Dyke, T. E. V., & Kantarcı, A. (2024) · Periodontology 2000 · doi:10.1111/prd.12603 · Cited by 24 · see citing works

Maresin-1 and its receptors RORα/LGR6 as potential therapeutic target for respiratory diseases

Zhao, M., Li, C., Zhang, J., Yin, Z., Zheng, Z., Wan, J., & Wang, M. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106337 · Cited by 24 · see citing works

Therapeutic potential of macrophage colony-stimulating factor in chronic liver disease

Keshvari, S., Genz, B., Teakle, N., Caruso, M., Ferrari-Cestari, M., Patkar, O. L., Tse, B. W., Sokolowski, K. A., Ebersbach, H., Jascur, J., et al. (2022) · Disease Models & Mechanisms · doi:10.1242/dmm.049387 · Cited by 22 · see citing works

Targeting HMG-CoA synthase 2 suppresses tamoxifen-resistant breast cancer growth by augmenting mitochondrial oxidative stress-mediated cell death

Hwang, S., Park, S., Kim, J. H., Bang, S.-B., Kim, H., Ka, N., Ko, Y., Kim, S.-S., Lim, G. Y., Lee, S., et al. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121827 · Cited by 22 · see citing works

Omega-3 pleiad: The multipoint anti-inflammatory strategy

Batista, E. D. S., Nakandakari, S. C. B. R., da Silva, A. S. R., Pauli, J. R., de Moura, L. P., Ropelle, E. R., Camargo, E. A., & Cintra, D. E. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2146044 · Cited by 21 · see citing works

Matrix stiffness regulates bone repair by modulating 12-lipoxygenase-mediated early inflammation

Yao, D., Qiao, F., Song, C., & Lv, Y. (2021) · Materials Science and Engineering C · doi:10.1016/j.msec.2021.112359 · Cited by 21 · see citing works

Lipid metabolism in tumor immunology and immunotherapy

Duong, L. K., Corbali, H. I., Riad, T. S., Ganjoo, S., Nanez, S., Voss, T. A., Barsoumian, H. B., Welsh, J. W., & Cortez, M. A. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1187279 · Cited by 21 · see citing works

Protective Potential of Maresins in Cardiovascular Diseases

Liu, M., He, H., & Chen, L. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.923413 · Cited by 19 · see citing works

Proresolving lipid mediators and liver disease

Clària, J., Flores‐Costa, R., Duran‐Güell, M., & López‐Vicario, C. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2021.159023 · Cited by 19 · see citing works

Deciphering the Potential Role of Specialized Pro-Resolving Mediators in Obesity-Associated Metabolic Disorders

Kim, N., & Shin, H. Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179598 · Cited by 18 · see citing works

The Role of Retinoic-Acid-Related Orphan Receptor (RORs) in Cellular Homeostasis

Nematisouldaragh, D., Kirshenbaum, E., Uzonna, M., Kirshenbaum, L. A., & Rabinovich-Nikitin, I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111340 · Cited by 18 · see citing works

Low serum Maresin-1 levels are associated with non-alcoholic fatty liver disease: a cross-sectional study

Xia, F., Wang, H., Ye, T., Fu, X.-L., Tan, X., Zeng, Y., Fan, J., & Xu, Y. (2021) · Lipids in Health and Disease · doi:10.1186/s12944-021-01518-5 · Cited by 18 · see citing works

Possibility of averting cytokine storm in SARS-COV 2 patients using specialized pro-resolving lipid mediators

Yasmeen, N., Selvaraj, H., Lakhawat, S. S., Datta, M., Sharma, P. K., Jain, A., Khanna, R., Srinivasan, J., & Kumar, V. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115437 · Cited by 17 · see citing works

Effects of high-fat diet on liver injury after small bowel resection

Onufer, E. J., Han, Y., Czepielewski, R. S., Courtney, C. M., Sutton, S., Randolph, G. J., & Warner, B. W. (2020) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2020.02.037 · Cited by 18 · see citing works

A cell-free difunctional demineralized bone matrix scaffold enhances the recruitment and osteogenesis of mesenchymal stem cells by promoting inflammation resolution

Yao, D., & Lv, Y. (2022) · Biomaterials Advances · doi:10.1016/j.bioadv.2022.213036 · Cited by 18 · see citing works

The use of circulating miRNAs for the diagnosis, prognosis, and personalized treatment of MASLD

Tobaruela-Resola, A. L., Milagro, F. I., Mogna-Peláez, P., Moreno-Aliaga, M. J., Abete, I., & Zulet, M. Á. (2025) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-025-01110-w · Cited by 17 · see citing works

Chemotactic cytokines secreted from Kupffer cells contribute to the sex-dependent susceptibility to non-alcoholic fatty liver diseases in mice

Han, Y., Choi, H., Kim, H., & Lee, M. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120846 · Cited by 17 · see citing works

Maresin-1 protects against pulmonary arterial hypertension by improving mitochondrial homeostasis through ALXR/HSP90α axis

Liu, M., He, H., Fan, F., Qiu, L.-J., Zheng, F., Guan, Y., Yang, G., & Chen, L. (2023) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2023.05.005 · Cited by 17 · see citing works

Oxylipins Derived from PUFAs in Cardiometabolic Diseases: Mechanism of Actions and Possible Nutritional Interactions

Ağagündüz, D., Yeşildemir, Ö., Koçyiğit, E., Koçak, T., Ünaldı, B. Ö., Ayakdaş, G., & Budán, F. (2024) · Nutrients · doi:10.3390/nu16223812 · Cited by 17 · see citing works

Pro-resolving lipid mediators in diseases: exploring the molecular basis and clinical implication

Li, C., Wang, Z., Yang, Y., Jiang, Q., Jiang, Y., Xiao, J., Shen, L., Wu, W., & Li, C. (2026) · Molecular Biomedicine · doi:10.1186/s43556-025-00400-5 · Cited by 19 · see citing works

Lipoxygenases in chronic liver diseases: current insights and future perspectives

Heinrich, L., Booijink, R. S., Khurana, A., Weiskirchen, R., & Bansal, R. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.12.001 · Cited by 16 · see citing works

IGF2-NR4A2 Signaling Regulates Macrophage Subtypes to Attenuate Liver Cirrhosis

Yao, L., Hu, X., Yuan, M., Zhang, Q., Liu, P., Yang, L., Dai, K., & Jiang, Y. (2023) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2022.00392 · Cited by 15 · see citing works

The Role of Endogenous Specialized Proresolving Mediators in Mast Cells and Their Involvement in Inflammation and Resolution

Fukuishi, N., Takahama, K., Kurosaki, H., Ono, S., & Asai, H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041491 · Cited by 17 · see citing works

Decreased Serum Maresin 1 Concentration Is Associated With Postmenopausal Osteoporosis: A Cross-Sectional Study

Wu, J. T., Li, X., Xia, F., Teng, F., & Xu, Y. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.759825 · Cited by 15 · see citing works

Maternal diabetes-mediated RORA suppression contributes to gastrointestinal symptoms in autism-like mouse offspring

Xiao, L., Wang, M., Zhang, W., Song, Y., Zeng, J., Li, H., Yu, H. Y., Li, L., Gao, P., & Yao, P. (2022) · BMC Neuroscience · doi:10.1186/s12868-022-00693-0 · Cited by 16 · see citing works

Maresins as novel anti-inflammatory actors and putative therapeutic targets in sepsis

Sun, Y., Sun, S., Chen, P., Dai, Y., Yang, D. J., Lin, Y., & Yi, L. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107113 · Cited by 15 · see citing works

Specialized Pro-Resolving Mediators Derived from N-3 Polyunsaturated Fatty Acids: Role in Metabolic Syndrome and Related Complications

Dubé, L., Spahis, S., Lachaîne, K., Lemieux, A., Monhem, H., Poulin, S.-M., Randoll, C., Travaillaud, E., Ould-Chikh, N.-E.-H., Marcil, V., et al. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0156 · Cited by 14 · see citing works

Exploiting oxidized lipids and the lipid‐binding GPCRs against cardiometabolic diseases

Guimarães, R. C., Gonçalves, T. T., & Leiria, L. O. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15321 · Cited by 13 · see citing works

Bioactive lipids and metabolic syndrome—a symposium report

DeVito, L. M., Dennis, E. A., Kahn, B. B., Shulman, G. I., Witztum, J. L., Sadhu, S., Nickels, J. T., Spite, M. R., Smyth, S. S., & Spiegel, S. (2022) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14752 · Cited by 13 · see citing works

Enzymatically-epoxidized docosahexaenoic acid, 19,20-EpDPE, suppresses hepatic crown-like structure formation and nonalcoholic steatohepatitis fibrosis through GPR120

Aoki, H., Isobe, Y., Yoshida, M., Kang, J. X., Maekawa, M., & Arita, M. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2022.159275 · Cited by 13 · see citing works

The pro-resolving lipid mediator Maresin 1 ameliorates pain responses and neuroinflammation in the spared nerve injury-induced neuropathic pain: A study in male and female mice

Teixeira-Santos, L., Martins, S., Sousa, T., Albino‐Teixeira, A., & Pinho, D. (2023) · PLoS ONE · doi:10.1371/journal.pone.0287392 · Cited by 13 · see citing works

Narrative Review: Glucocorticoids in Alcoholic Hepatitis—Benefits, Side Effects, and Mechanisms

Lü, H. (2022) · Journal of Xenobiotics · doi:10.3390/jox12040019 · Cited by 13 · see citing works

n-3 polyunsaturated fatty acids regulate chemerin in cultured adipocytes: role of GPR120 and derived lipid mediators

Sáinź, N., Fernández‐Galilea, M., Costa, A. G. V., Prieto-Hontoria, P. L., Barraco, G. M., & Moreno-Aliaga, M. J. (2020) · Food & Function · doi:10.1039/d0fo01445a · Cited by 13 · see citing works

Mouse models of nonalcoholic steatohepatitis and their application to new drug development

Phung, H. H., & Lee, C. H. (2022) · Archives of Pharmacal Research · doi:10.1007/s12272-022-01410-5 · Cited by 13 · see citing works

The Proresolving Lipid Mediator Maresin1 Alleviates Experimental Pancreatitis via Switching Macrophage Polarization

Lu, Y., Lu, G., Gao, L., Zhu, Q., Xue, J., Zhang, J., Ma, X., Ma, N., Yang, Q., Dong, J., et al. (2021) · Mediators of Inflammation · doi:10.1155/2021/6680456 · Cited by 12 · see citing works

Exosome‐derived miR ‐142‐5p from liver stem cells improves the progression of liver fibrosis by regulating macrophage polarization through CTSB

Hu, Z., Zhao, Y., Jiang, J., Li, W., Su, G., Li, L., & Ran, J. (2023) · Environmental Toxicology · doi:10.1002/tox.23813 · Cited by 12 · see citing works

Resolving inflammation in nonalcoholic steatohepatitis

Spite, M. R. (2019) · Journal of Clinical Investigation · doi:10.1172/jci127583 · Cited by 9 · see citing works

RORα Induces KLF4-Mediated M2 Polarization in the Liver Macrophages that Protect against Nonalcoholic Steatohepatitis

Han, Y., Kim, H., Na, H., Nam, M.-W., Kim, J.-Y., Kim, J.-S., Koo, S., & Lee, M.-O. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.06.017 · Cited by 150 · see citing works

RORα Decreases Oxidative Stress Through the Induction of SOD2 and GPx1 Expression and Thereby Protects Against Nonalcoholic Steatohepatitis in Mice

Han, Y., Kim, H., Kim, E., Kim, K.-S., Hong, S., Park, H., & Lee, M. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5655 · Cited by 84 · see citing works

Nobiletin Alleviates Non-alcoholic Steatohepatitis in MCD-Induced Mice by Regulating Macrophage Polarization

Wang, S.-W., Lan, T., Sheng, H., Zheng, F., Lei, M.-K., Wang, L.-X., Chen, H.-F., Xu, C.-Y., & Zhang, F. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.687744 · Cited by 28 · see citing works

Resolvin D1 mitigates non-alcoholic steatohepatitis by suppressing the TLR4-MyD88‐mediated NF‐κB and MAPK pathways and activating the Nrf2 pathway in mice

Li, J., Deng, X., Bai, T., Wang, S., Jiang, Q., & Xu, K. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106961 · Cited by 55 · see citing works